Objective: The study aimed to investigate the role and level of resistin and correlation some biochemical parameters (ox-LDL, Hcy, LDL-C, TC, HDL, BMI and lipid peroxidation MDA), Antioxidant (GSH, A, C, E), also we studied familial hypercholesterolemia (FH) to investigate the effects of MTHFR gene mutation. 
INTRODUCTION
Hypercholesterolemia is clinically characterized by an increase of the total and low-density lipoprotein (LDL) cholesterol in plasma. It represents a high risk for the development of atherosclerosis (1) were also free radicals play a significant role (2) because they are able to oxidatively damage different molecules. One of the most examined free radical damages is an oxidative damage to lipids in the process of lipoperoxidation. Increased lipid peroxidation has been identified as a key mechanism for the development of atherosclerosis by {Harrison et al.2003 ] (3). According to the original oxidative hypothesis of atherosclerosis, oxidative modification of plasma lipoproteins migrated in the subendothelium exerts pro-inflammatory activities and is the necessary condition for the development of atheroma and its complication (4) Cholesterol is essential for the body, specifically for hormone synthesis, fat digestion, and formation of cell membranes (5) . However, large amounts of cholesterol in the bloodstream lead tomyocardial infarction, stroke, ischemic injury, and organ failure (6) .
Serum resistin was positively correlated with changes of BMI and body adipose mass.
Circulating resistin levels increase with age, probably reflecting the increase in the body fat content. With human obesity elevated serum resistin levels were observed when compared with humans in lean condition. Resistin is involved in the proliferation of adiposities and angiogenesis (7) . FH is a genetic alteration of lipoprotein metabolism caused by defects in the low density lipoprotein receptor (LDLR) High LDL levels, secondary to the LDLR homozygous defect, are associated to significant increase of oxidized LDL (ox-LDL), which removed from circulation lead to massive lipid accumulation, foam cell formation in endothelial wall, often tendom xanthomas (TX) and corneal arcus (8) . The generation of free radicals and a subsequent increase in oxidative stress is a by-product of an inflammatory environment (9, 10) . There are several enzymatic and nonenzymatic antioxidant defense systems acting against the harmful effects of these reactive oxygen species. Under normal circumstances, there is a balance between the oxidants and antioxidants. However, excessive production of the reactive oxygen species or decreased antioxidant activity causes an oxidative stress (11) . The level of GSH in the plasma is likely to be more reflective of tissue intracellular GSH status than the more commonly and more easily measure red blood cell or whole blood GSH levels because red blood cells are normally net producers of GSH. GSH is involved in the intracellular metabolism of vitamin B12. Adequate GSH levels are needed to avoid B12 deficiency and insufficient methylcobalamin to support methionine synthase in the methylation cycle. Normally oxidised GSH (GSSG) is recycled back to reduced GSH by GSH reductase which requires B2. If GSSG is elevated above normal range, this represents oxidative stress. Homocysteine is an amino acid associated with atherosclerosis that can become elevated when there is need for folate, vitamin B6, and/or vitamin B12. Excess homocysteine levels have been correlated with many cardiovascular disorders (12) .
Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by primary hypercholesterolemia and premature coronary artery disease (CAD). However, the development of CAD in FH shows considerable inter individual variations. Elevated levels of plasma homocysteine have been recognized as independent risk factors for CAD (13) .
MTHFR is critical enzyme both folate and homocysteine metabolism, it first achieved medical recognition in severe deficiency of MTHFR in patient with homocysteine in plasma and urine (14) . The 5, 10-Methylenetetrahydrofolate reductase (MTHFR) gene is located on short arm (p) of the chromosome 1 at (1p36.3). MTHFR gene spans a 2.2Kb length with 11exons and 10 introns (15) ranging in size from 103 base pairs (bp) to 432 bp, is approximately 2.2 kb.
Several mutations in the MTHFR gene have been identified, but most are rare and associated with severe enzymatic deficiency. However, in contrast with these rarities, two common thermolabile single-nucleotide polymorphisms (SNPs) in the MTHFR gene (C677T and A1298C) deserve special mention in Chronic Myeloid Leukemia susceptibility because they result in a decrease in MTHFR activity, and its possible consequent effects mentioned above (16) . In humans, the majors products of the MTHFR gene is catalytically active 77-kilodalton protein, although a smaller isoform of approximately protein, although a smaller isoform of approximately 70 kilodaltons have been observed in some tissue (15, 17, 18) .
MATERIAL AND METHODS
We enrolled 64 consecutive patients (33 female) and (31 males) who attend Rizgary teaching hospital , the province of Erbil , Iraq , between November 2014-march2015 and the intensive care cardiac samples were suffer from hypercholesterolemia and FH disease and they were aged between 25-50 years , were divided in two groups hypercholesterolemia in blood and FH.
Control groups: 80 samples fasten from healthy people (40female 40 male) of the same age groups.
Blood collection and (biochemistry and genetic study) analysis
Blood samples (5 ml) were collected , fasting blood sample were divided in two parts , the first part used to analyze (LDL-C,HDL-C,TC) commercial diagnostic kits from (BDH) company, serum samples collected for estimation were frozen at (-80 ͦ C) for estimation (resistin, ox-LDL and Hcy) were obtained from MyBiosource company ,USA depend on ELISA. The MDA level in the serum of groups were examined using uchiyama and Mihara methods (19) the method is based on the production of pink company producing maximum absorbance at 535 nm as a result of thioybarbutixic acid's reaction with MDA , the GSH level was examined using the Ellman's method(20) antioxidant (A,E,C) vitamins were determined by manual methods asin case and control groups , vitamin E depending on Emmerie-Engel reaction (21), vitamin C by using 2,4-dinitrophenyl hydrazine (DNPH) method (22), vitamin A determination by using methods which depending on By breaking down the vitamin A by UV rays, and taking the absorbance at the wavelength (327nm) (23, 24).
The second part from the blood using to identify mutations in the gene responsible for enzyme methylenetetrahydrofolate reductase (MTHFR) Genomic deoxyribonucleic was purified from peripheral white blood cells two females with hypercholesterolemia and FH, measure the concentration and purity DNA by using (Roche, Germany) kit, Quantification and qualification of DNA concentration were performed using a spectrophotometer Nano drop (25). And its amplifications were performed by polymerase chain reaction. Analysis for MTHFR gene exon 4 performed using primers. table1. Using the following PCR thermal program initial denaturation at 95C° for 5minutes, followed by 30cycles for denaturation at 30seconds, annealing at 59C° for exone 15 for 30seconds and elongation at 72C° for 30seconds. After the last cycle a final extention at72C° for minutes was performed. The result ant PCR products were; separated and visualized a 2%agarose gel stained with ethidome bromide Fig 3. DNA sequencing of PCRamplified product was carried out bi-directionally (Sambrook and Russell) method (26).
Statistical analysis
The data are expressed as mean values with stander deviation (SD) for variable with normal distribution. Statistical differences were computer by using the students test. Statistical analysis were performed with SPSS software (Version 13.0) in significance statistical.
RESULTS
The results show 
DISCUSSION
The result on (28), however resistin association with inflammatory markers appear to be independent of BMI ,suggest that resistin may have a direct pro inflammatory role or mediate its effects via yet to be discovered obesity independent mechanisms (29, 30). Resistin expression in adiposetissue adipocytes and macrophages is increased in obesity, leading to increased circulating resistin levels. There are also strong positive correlations between plasma resistin levels and increases in body mass index (BMI) and visceral fat (31) .and The relationship between BMI and risk of CVD is well established in some studies (32) , BMI is positively associated with serum cholesterol level in middle-age men and the changing in cholesterol levels over the six-year follow-up was significantly related to the changing in BMI. Alterations in lipid and lipoprotein concentrations and changing the CVD risk factors agree with some studies (33) . The association between hypercholesterolemia and BMI in men and women was not the same. In early middleage the risk of hypercholesterolemia in obese people was more than overweight people while in older age this relation was increased in overweight men without significant differences in women.
The association between serum cholesterol levels and BMI based on age and gender was reported in other studies. Serum cholesterol level increased with age BMI. Alteration in serum cholesterol levels was related to lifestyle factors in some areas (34) . the effects of changing body weight on plasma cholesterol concentrations may also vary with level of adiposity, as some studies suggest greater increases with weight gain among nonobese than obese men and women. Aside from the results show significant decrease on ox-LDL-C (for female and male) with FH the reason may be due Statins, 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors, are known to reduce LDL-C concentrations. Atorvastatin is one of the most widely used statins in the primary and secondary prevention of CVD. The benefit of statin therapy is related not only to its lipid-lowering but also its anti-inflammatory and antioxidant properties (leading to enhanced endothelial function and reduced plaque burden). These pleiotropic effects that are independent of LDL-C-lowering action have drawn recently special attention (37).
On the other hand the results show significant increase in LDL-C for male with hypercholesterolemia and female with FH also the results indicates significant decrease in HDL-C for (female and male) with (hypercholesterolemia and FH), many epidemiologic data suggest that hypercholesterolemia is the main contributor for atherogenesis, several studies have suggested that hypercholesterolemia is associated with lifestyle habits, like dietary, smoking and physical inactivity status. Despite these considerations, the management of blood lipids levels is difficult, especially in older adults. The effect of abnormal blood lipids levels on cardiovascular system is enhanced with increased age (38) .
The results show significant increase in TC for (female and male) with (hypercholesterolemia and FH) high level of blood cholesterol is usually associated with an increased risk for the development and progression of coronary artery disease and consequently of ischemic heart disease (39) .patients with FH have elevated low-density lipoprotein (LDL) cholesterol levels leading to coronary heart disease(CHD) early in life ,The risk of CHD is very high in patients with familial hypercholesterolaemia mainly because of high total and LDL cholesterol plasma levels. Furthermore, familial hypercholesterolaemia is often associated with decreased HDL cholesterol levels (40) . should not only focus on lowering total and LDL cholesterol levels, but also on increasing HDL cholesterol for the prevention of coronary heart disease in this high risk group. More prospective and intervention trials should be conducted to establish the relationship between HDL cholesterol levels and coronary heart disease in familial hypercholesterolaemia (41, 42) .
The results show highly signification in MDA the reason may be due to evolution of hypercholesterolemia is associated with endothelial cell dysfunction (43) . Additionally, reports have shown a near-complete abrogation in vascular nitric oxide (NO) bioavailability, elevated oxidant stress, and the creation of a strongly pro-inflammatory condition; symptoms which can culminate in profound impairments to vascular reactivity. Investigation into vascular consequences of chronic hypercholesterolemia, the mechanisms through which these consequences occur, and the potentially beneficial effects of ameliorative therapies have received considerable attention in recent years. Excess oxidative stress is caused by an imbalance between pro and anti-oxidant enzymes, leading to an overproduction of free radicals, including superoxide, hydroxyl radicals, and lipid radicals, which may damage cellular components (44) . . These alterations in the levels of serum lipid peroxide and antioxidant status in subjects with higher serum TC, LDL-C, and lower HDL-C levels may increase the susceptibility of LDL to oxidation in the circulation. As a lipid peroxidation process leading to increased atherogenity of LDL, it follows that antioxidant status should have a major impact not only on the rate of LDL oxidation but perhaps on development of atherosclerosis. It is possible that a potential risk of atherosclerosis in higher lipid group was associated with LDL oxidation as a result of increased levels of LDL-C and decreased antioxidant (48) .
The results explained significant decrease in GSH for both (male and female) with (hypercholesterolemia and FH), endogenous non-enzymatic defense system against oxidative stress is including the sulphadryl containing peptide namely GSH. It is widely distributed in all biological tissues. GSH inhibits ROS oxidative injuries directly via its sulfhydryl group and indirectly as a cofactor or a coenzyme in ROS enzymatic detoxification process (49) .
GSH can be directly oxidized by ROS and RNS or indirectly during GSH dependent peroxidase-catalyzed reactions. Conjugation with endogenous and exogenous electrophiles consumes a substantial portion of cellular GSH (50) . GSH plays an important role in the antioxidant defense system, in the metabolism of various nutrients and in the regulation of cellular events including DNA damage, gene expression and apoptosis where its deficiency contributes to oxidative stress. However, these effects of GSH on the mechanisms of lipid and protein oxidation need to be better elucidated (17) .
On the other hand the results show significant decrease in vitamin (A,C,E) level for both (male and female) with both (hypercholesterolemia and FH), as well as the results show significant increase for both (male and female) with both (hypercholesterolemia and FH) the reason may be Elevated levels of homocysteine are an independent risk factor for cardiovascular diseases. Homocysteine may contribute to enhanced oxidative inactivation of nitric oxide by its redox activity, which arises from the formation of disulfides and the generation of hydrogen peroxide and superoxide anion (51) . Elevated Hcy level has been shown to be a risk factor for myocardial infarction and stroke. Some limited studies showed that elevated Hcy may increase the risk of retinal vascular diseases such as retinal artery and retinal vein thrombosis and occlusion. Hcy induced vascular problems may be multifactorial, including direct Hcy damage to the endothelium, enhanced LDL peroxidation, and increased platelet aggregation by the effects on the coagulation system (52) . Recently, homocysteine has been employed successfully as an independent predictor of atherosclerotic events and of carotid intimal-medial thickness in hyperlipidemic subjects. Several clinical studies also suggest that a high homocysteine level increases the risk of heart attack in children with familial hypercholesterolemia. An elevated homocysteine level is also found to interact strongly with hypertension and smoking as well as with hypercholesterolemia. The combined effect is manifested in both sexes, but appears to be more pronounced in women. The interactive effect with conventional risk factors, especially with smoking and hypertension, suggests that homocysteine may further enhance the cardiovascular risk in these patients (53) .
GSH level connected with enzyme MTHFR which have an important role in homocysteine metabolism by catalyzing the conversion of 5, 10-methylene tertrahydrofolate to 5-methylene tertrahydrofolate, and the methyl-group donor in the B12-dependent remethylation of homocysteine to methionine. The Study proves that severe deficiency of the MTHFR enzyme advance to homocystinuria which is a rare inborn error of metabolism symbolizes by highly increased blood and urine homocysteine concentrations. Thus the reduction in MTHFR level promotes to hyperhomocysteinemia, Represent by increased plasma total homocysteine (Hcy) levels, and is frequently observed in patients with vascular diseases (54) .
Some studies shows the importance of the homocysteine-dependent transsulfuration pathway in the maintenance of the intracellular GSH pool, and the regulation of this pathway under oxidative stress conditions (55) . Studies with purified mammalian methionine synthase and cystathionine beta-synthase have revealed the oxidative sensitivity of both junction enzymes, suggesting the hypothesis that redox regulation of this pathway may be physiologically significant. GSH appears to have marked antioxidant activities and therefore may prevent cardiovascular disease. It was suggested that reduced plasma GSH level is a risk factor for development of cardiovascular and cerebrovascular diseases (56) .
Homocysteine is metabolized through two main pathways: Remethylation to methionine or transsulfuration to cystathionine and then to cysteine. A decrease in the rate of remethylation of homocysteine into methionine produces hyperhomocysteinemia. It is recognized that hyperhomocysteinemia produces thrombogenesis, vasodilation and endothelial damage and is associated with cardiovascular and cerebrovascular diseases (57) .experimental evidence suggests that homocysteine may promote atherogenesis through its toxic effects on the vascular endothelium, which is likely mediated through oxidative stress (58) . 
